Histone deacetylase as a target for cancer therapy

被引：0
|
作者：
La Thangue, N
Brown, R
Finn, P
Williams, R
机构：
[1] Univ Glasgow, Div Biochem & Mol Biol, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland
[2] CR UK Beatson Labs, Dept Med Oncol, Glasgow G61 1BD, Lanark, Scotland
[3] Prolifix Ltd, Abingdon OX14 4RY, Oxon, England
来源：
BRITISH JOURNAL OF CANCER | 2002年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S9 / S10
页数：2
相关论文
共 50 条
  • [41] Multi-Targeted Histone Deacetylase Inhibitors in Cancer Therapy
    Ai, T.
    Cui, H.
    Chen, L.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (04) : 475 - 487
  • [42] Liposomes loaded with histone deacetylase inhibitors for breast cancer therapy
    Urbinati, Giorgia
    Marsaud, Veronique
    Plassat, Vincent
    Fattal, Elias
    Lesieur, Sylviane
    Renoir, Jack-Michel
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 397 (1-2) : 184 - 193
  • [43] Hybrid Histone Deacetylase Inhibitor: An Effective Strategy for Cancer Therapy
    Wu, Jiyong
    Nie, Jing
    Luan, Yepeng
    Ding, Yanjiao
    CURRENT MEDICINAL CHEMISTRY, 2023, 30 (20) : 2267 - 2311
  • [44] Histone deacetylase inhibitors in programmed cell death and cancer therapy
    Marks, PA
    Jiang, XJ
    CELL CYCLE, 2005, 4 (04) : 549 - 551
  • [45] The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy
    Psilopatis, Iason
    Garmpis, Nikolaos
    Garmpi, Anna
    Vrettou, Kleio
    Sarantis, Panagiotis
    Koustas, Evangelos
    Antoniou, Efstathios A.
    Dimitroulis, Dimitrios
    Kouraklis, Gregory
    Karamouzis, Michail V.
    Marinos, Georgios
    Kontzoglou, Konstantinos
    Nonni, Afroditi
    Nikolettos, Konstantinos
    Fleckenstein, Florian N.
    Zoumpouli, Christina
    Damaskos, Christos
    CANCERS, 2023, 15 (08)
  • [46] Nanotechnology-Based Histone Deacetylase Inhibitors for Cancer Therapy
    Tu, Bin
    Zhang, Meng
    Liu, Tuanbing
    Huang, Yongzhuo
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [47] Histone deacetylase inhibitors open new doors in cancer therapy
    McLaughlin, F
    La Thangue, NB
    BIOCHEMICAL PHARMACOLOGY, 2004, 68 (06) : 1139 - 1144
  • [48] Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy
    Kraft, Fabian B.
    Hanl, Maria
    Feller, Felix
    Schaeker-Huebner, Linda
    Hansen, Finn K.
    PHARMACEUTICALS, 2023, 16 (03)
  • [49] Histone deacetylase 2 selective inhibitors: A versatile therapeutic strategy as next generation drug target in cancer therapy
    Shetty, Manasa Gangadhar
    Pai, Padmini
    Deaver, Renita Esther
    Satyamoorthy, Kapaettu
    Babitha, Kampa Sundara
    PHARMACOLOGICAL RESEARCH, 2021, 170
  • [50] Histone Deacetylation An Attractive Target for Cancer Therapy?
    Al-Janadi, Anas
    Chandana, Sreenivasa R.
    Conley, Barbara A.
    DRUGS IN R&D, 2008, 9 (06) : 369 - 383
12345